Vertex Pharmaceuticals Inc / Ma

Swiss National Bank VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

702,600

Value ($000)

318,531

Weight

0.2%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	318,531	0.2%	702,600	12/31/2025
2025 Q3	11/13/2025	289,931	0.2%	740,300	9/30/2025
2025 Q2	8/12/2025	346,499	0.2%	778,300	6/30/2025
2025 Q1	5/12/2025	352,076	0.2%	726,200	3/31/2025
2024 Q4	2/10/2025	293,649	0.2%	729,200	12/31/2024
2024 Q3	11/7/2024	356,251	0.2%	766,000	9/30/2024
2024 Q2	8/8/2024	358,477	0.2%	764,800	6/30/2024
2024 Q1	5/7/2024	322,578	0.2%	771,700	3/31/2024
2023 Q4	2/6/2024	328,401	0.2%	807,100	12/31/2023
2023 Q3	11/8/2023	288,068	0.2%	828,400	9/30/2023
2023 Q2	8/9/2023	327,382	0.2%	930,300	6/30/2023
2023 Q1	5/10/2023	320,993	0.2%	1,018,800	3/31/2023
2022 Q4	2/8/2023	301,024	0.2%	1,042,400	12/31/2022
2022 Q3	11/9/2022	320,919	0.2%	1,108,375	9/30/2022
2022 Q2	8/9/2022	311,174	0.2%	1,104,275	6/30/2022
2022 Q1	5/9/2022	287,374	0.2%	1,101,175	3/31/2022
2021 Q4	2/8/2022	216,542	0.1%	986,075	12/31/2021
2021 Q3	11/8/2021	185,684	0.1%	1,023,675	9/30/2021
2021 Q2	8/6/2021	213,723	0.1%	1,059,975	6/30/2021
2021 Q1	5/7/2021	319,966	0.2%	1,488,975	3/31/2021
2020 Q4	2/5/2021	346,823	0.2%	1,467,475	12/31/2020
2020 Q3	11/9/2020	378,294	0.3%	1,390,175	9/30/2020
2020 Q2	8/5/2020	344,242	0.3%	1,185,775	6/30/2020
2020 Q1	5/8/2020	246,534	0.3%	1,036,075	3/31/2020
2019 Q4	2/6/2020	181,767	0.2%	830,175	12/31/2019
2014 Q2	8/6/2014	21,758	0.1%	229,809	6/30/2014
2014 Q1	5/6/2014	16,019	0.1%	226,509	3/31/2014
2013 Q4	1/31/2014	18,434	0.1%	248,109	12/31/2013